نتایج جستجو برای: antileukemic activity

تعداد نتایج: 1134946  

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تربیت مدرس - دانشکده علوم پزشکی 1389

introduction: diabetes mellitus is an growing national and international public health concern. the number of people affected by diabetes in world by 2030 will be 69% in developing countries. regular physical activity plays a key role in the management of type 2 diabetes melitus, particularly glycemic control. it has been recommended that peoples with type 2 diabetes participate in moderate-int...

Journal: :Molecular pharmacology 2010
Jessica K Altman Heather Glaser Antonella Sassano Sonali Joshi Takeshi Ueda Rie Watanabe-Fukunaga Rikiro Fukunaga Martin S Tallman Leonidas C Platanias

Mnk kinases are downstream effectors of mitogen-activated protein kinase pathways and mediate phosphorylation of the eukaryotic initiation factor (eIF4E), a protein that plays a key role in the regulation of mRNA translation and is up-regulated in acute myeloid leukemia (AML). We determined the effects of chemotherapy (cytarabine) on the activation status of Mnk in AML cells and its role in the...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Nitin Jain Emily Curran Neil M Iyengar Ernesto Diaz-Flores Rangesh Kunnavakkam Leslie Popplewell Mark H Kirschbaum Theodore Karrison Harry P Erba Margaret Green Xavier Poire Greg Koval Kevin Shannon Poluru L Reddy Loren Joseph Ehab L Atallah Philip Dy Sachdev P Thomas Scott E Smith L Austin Doyle Walter M Stadler Richard A Larson Wendy Stock Olatoyosi Odenike

PURPOSE The clinical relevance of targeting the RAS/RAF/MEK/ERK pathway, activated in 70% to 80% of patients with acute myelogenous leukemia (AML), is unknown. EXPERIMENTAL DESIGN Selumetinib is an oral small-molecule inhibitor of MAP-ERK kinase (MEK)-1/2. Forty-seven patients with relapsed/refractory AML or 60 years old or more with untreated AML were enrolled on a phase II study. Patients w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید